首页> 外国专利> DUAL-CONTROLLED DRUG AND PHOTOACTIVATABLE SYSTEM FOR SPATIOTEMPORAL CONTROL OF CELL THERAPY

DUAL-CONTROLLED DRUG AND PHOTOACTIVATABLE SYSTEM FOR SPATIOTEMPORAL CONTROL OF CELL THERAPY

机译:双控药物和光活化系统,用于细胞疗法的时空控制

摘要

Provided are compositions, including products of manufacture and kits, and methods, for remotely-controlled and non-invasive manipulation of intracellular nucleic acid expression, genetic processes, function and activity in live cells such as a T cell, a primary T cell, a B cell, a monocyte, a macrophage, a dendritic cell or a natural killer cell in vivo, for example, including activating, adding functions or changing or adding specificities for an immune cell, for monitoring physiologic processes, for the correction of pathological processes and for the control of therapeutic outcomes. Provided are tamoxifen-gated photoactivatable split-Cre recombinase optogenetic systems, called TamPA-Cre, that feature high spatiotemporal control to control or alter cell activities in vivo, for example, to limit the activity of a Chimeric Antigen Receptor (CAR)-expressing cell such as an immune cell and its activity at a tumor site for immunotherapy applications.
机译:提供的是组合物,包括制造和试剂盒的产品,以及用于远程控制和非侵入性的细胞内核酸表达,遗传过程,功能和活性在活细胞中的非侵入性操纵,例如T细胞,初级T细胞,a B细胞,单核细节,巨噬细胞,树突状细胞或天然杀伤细胞,例如,包括激活,增加功能或改变或增加免疫细胞的特异性,用于监测生理过程,用于纠正病理过程和治疗结果的控制。提供的是他莫昔芬腺控定位的分裂CRE重组酶致敏系统,称为TAMPA-CRE,其具有高时的时尚控制,以控制或改变细胞活性在体内,例如,限制嵌合抗原的活性受体(汽车) - 抑制细胞如免疫细胞及其在肿瘤部位的免疫疗法应用中的活性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号